InvestorsHub Logo
Followers 12
Posts 1139
Boards Moderated 0
Alias Born 02/13/2018

Re: None

Saturday, 12/26/2020 10:12:54 AM

Saturday, December 26, 2020 10:12:54 AM

Post# of 233745
I’m still hopeful a Nasdaq uplisting comes in the next 1-2 weeks. Access to institutional investors will send this company through the roof as EUA/FDA approval becomes imminent

My concern is on the production side. I’m not sure if there’s a mechanism for the government to intervene but the available stock is a fraction of what the demand will be. Additionally, following FDA approval, the use for “off label” indications will be substantial. Not sure how third party reimbursement will approach this, but I have no doubt that this will be implemented at earlier stages in treatment algorithms. Trying to prevent progression to “severe” stages is key to any disease process. Reign in the inflammatory and immune dysregulation responsible for killing people.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News